{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T17:19:37Z","timestamp":1764782377471,"version":"build-2065373602"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T00:00:00Z","timestamp":1686614400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T00:00:00Z","timestamp":1686614400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pathologie"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s00292-023-01207-3","type":"journal-article","created":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T21:01:42Z","timestamp":1686690102000},"page":"294-300","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Colitis-ulcerosa-assoziierte Karzinogenese","Ulcerative colitis-associated carcinogenesis"],"prefix":"10.1007","volume":"44","author":[{"given":"Daniela E.","family":"Aust","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo B.","family":"Baretton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Sommer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,13]]},"reference":[{"key":"1207_CR1","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1056\/NEJMoa2017699","volume":"383","author":"T Andr\u00e9","year":"2020","unstructured":"Andr\u00e9\u00a0T, Shiu\u00a0K\u2011K, Kim\u00a0TW et al (2020) Pembrolizumab in microsatellite-instability\u2013high advanced colorectal cancer. N\u00a0Engl J Med 383:2207\u20132218","journal-title":"N Engl J Med"},{"key":"1207_CR2","first-page":"130","volume":"83","author":"DE Aust","year":"1999","unstructured":"Aust\u00a0DE, Baretton\u00a0GB, Waldman\u00a0FM et al (1999) Molecular carcinogenesis in ulcerative colitis-associated and sporadic colorectal carcinoma--differences and similarities. Verh Dtsch Ges Pathol 83:130\u2013138","journal-title":"Verh Dtsch Ges Pathol"},{"key":"1207_CR3","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1002\/cncr.10334","volume":"94","author":"DE Aust","year":"2002","unstructured":"Aust\u00a0DE, Terdiman\u00a0JP, Willenbucher\u00a0RF et al (2002) The APC\/beta-catenin pathway in ulcerative colitis-related colorectal carcinomas: a\u00a0mutational analysis. Cancer 94:1421\u20131427","journal-title":"Cancer"},{"key":"1207_CR4","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1055\/a-0824-0861","volume":"57","author":"Authors and Collaborators","year":"2019","unstructured":"Authors and Collaborators (2019) Updated S3-guideline ulcerative colitis. German society for digestive and metabolic diseases (DGVS). Z\u00a0Gastroenterol 57:162\u2013241","journal-title":"Z Gastroenterol"},{"key":"1207_CR5","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1007\/s10620-018-5378-8","volume":"64","author":"M Bajpai","year":"2019","unstructured":"Bajpai\u00a0M, Seril\u00a0DN, Van Gurp\u00a0J et al (2019) Effect of long-term mesalamine therapy on cancer-associated gene expression in colonic mucosa of patients with ulcerative colitis. Dig Dis Sci 64:740\u2013750","journal-title":"Dig Dis Sci"},{"key":"1207_CR6","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1056\/NEJMra1403718","volume":"372","author":"L Beaugerie","year":"2015","unstructured":"Beaugerie\u00a0L, Itzkowitz\u00a0SH (2015) Cancers complicating inflammatory bowel disease. N\u00a0Engl J Med 372:1441\u20131452","journal-title":"N Engl J Med"},{"key":"1207_CR7","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1093\/carcin\/bgh091","volume":"25","author":"J Biarc","year":"2004","unstructured":"Biarc\u00a0J, Nguyen\u00a0IS, Pini\u00a0A et al (2004) Carcinogenic properties of proteins with pro-inflammatory activity from streptococcus infantarius (formerly S.bovis). Carcinogenesis 25:1477\u20131484","journal-title":"Carcinogenesis"},{"key":"1207_CR8","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1111\/apt.13897","volume":"45","author":"F Carrat","year":"2017","unstructured":"Carrat\u00a0F, Seksik\u00a0P, Colombel\u00a0JF et\u00a0al (2017) The effects of aminosalicylates or thiopurines on the risk of colorectal cancer in inflammatory bowel disease. Aliment Pharmacol Ther 45:533\u2013541","journal-title":"Aliment Pharmacol Ther"},{"key":"1207_CR9","doi-asserted-by":"publisher","first-page":"6580","DOI":"10.1158\/1078-0432.CCR-12-1362","volume":"18","author":"DS Chen","year":"2012","unstructured":"Chen\u00a0DS, Irving\u00a0BA, Hodi\u00a0FS (2012) Molecular pathways: next-generation immunotherapy--inhibiting programmed death-ligand 1 and programmed death\u20111. Clin Cancer Res 18:6580\u20136587","journal-title":"Clin Cancer Res"},{"key":"1207_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","volume":"39","author":"DS Chen","year":"2013","unstructured":"Chen\u00a0DS, Mellman\u00a0I (2013) Oncology meets immunology: the cancer-immunity cycle. Immunity 39:1\u201310","journal-title":"Immunity"},{"key":"1207_CR11","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1159\/000508328","volume":"102","author":"X Fan","year":"2021","unstructured":"Fan\u00a0X, Jin\u00a0Y, Chen\u00a0G et\u00a0al (2021) Gut microbiota dysbiosis drives the development of colorectal cancer. Digestion 102:508\u2013515","journal-title":"Digestion"},{"key":"1207_CR12","first-page":"4864","volume":"60","author":"AS Fleisher","year":"2000","unstructured":"Fleisher\u00a0AS, Esteller\u00a0M, Harpaz\u00a0N et al (2000) Microsatellite instability in inflammatory bowel disease-associated neoplastic lesions is associated with hypermethylation and diminished expression of the DNA mismatch repair gene, hMLH1. Cancer Res 60:4864\u20134868","journal-title":"Cancer Res"},{"key":"1207_CR13","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.cell.2016.08.069","volume":"167","author":"J Gao","year":"2016","unstructured":"Gao\u00a0J, Shi\u00a0LZ, Zhao\u00a0H et al (2016) Loss of IFN\u2011\u03b3 pathway genes in tumor cells as a\u00a0mechanism of resistance to anti-CTLA\u20114 therapy. Cell 167:397\u2013404.e9","journal-title":"Cell"},{"key":"1207_CR14","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1093\/ecco-jcc\/jjv145","volume":"9","author":"J Gordillo","year":"2015","unstructured":"Gordillo\u00a0J, Cabre\u00a0E, Garcia-Planella\u00a0E et al (2015) Thiopurine therapy reduces the incidence of colorectal neoplasia in patients with ulcerative colitis. Data from the ENEIDA registry. J\u00a0Crohns Colitis 9:1063\u20131070","journal-title":"J Crohns Colitis"},{"key":"1207_CR15","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1093\/carcin\/bgs006","volume":"33","author":"L Hartnett","year":"2012","unstructured":"Hartnett\u00a0L, Egan\u00a0LJ (2012) Inflammation, DNA methylation and colitis-associated cancer. Carcinogenesis 33:723\u2013731","journal-title":"Carcinogenesis"},{"key":"1207_CR16","doi-asserted-by":"publisher","first-page":"6091","DOI":"10.3390\/curroncol29090479","volume":"29","author":"W Li","year":"2022","unstructured":"Li\u00a0W, Zhao\u00a0T, Wu\u00a0D et\u00a0al (2022) Colorectal cancer in ulcerative colitis: mechanisms, surveillance and chemoprevention. Curr Oncol 29:6091\u20136114","journal-title":"Curr Oncol"},{"key":"1207_CR17","doi-asserted-by":"publisher","first-page":"188447","DOI":"10.1016\/j.bbcan.2020.188447","volume":"1874","author":"DY Lizardo","year":"2020","unstructured":"Lizardo\u00a0DY, Kuang\u00a0C, Hao\u00a0S et al (2020) Immunotherapy efficacy on mismatch repair-deficient colorectal cancer: from bench to bedside. Biochim Biophys Acta Rev Cancer 1874:188447","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"1207_CR18","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3389\/fimmu.2018.00072","volume":"9","author":"Y Lu","year":"2018","unstructured":"Lu\u00a0Y, Li\u00a0X, Liu\u00a0S et al (2018) Toll-like receptors and inflammatory bowel disease. Front Immunol 9:72","journal-title":"Front Immunol"},{"key":"1207_CR19","doi-asserted-by":"publisher","first-page":"772101","DOI":"10.3389\/fphar.2021.772101","volume":"12","author":"M Lucafo","year":"2021","unstructured":"Lucafo\u00a0M, Curci\u00a0D, Franzin\u00a0M et\u00a0al (2021) Inflammatory bowel disease and risk of colorectal cancer: an overview from pathophysiology to pharmacological prevention. Front Pharmacol 12:772101","journal-title":"Front Pharmacol"},{"issue":"1","key":"1207_CR20","doi-asserted-by":"publisher","first-page":"13077","DOI":"10.1038\/s41598-021-92530-3","volume":"11","author":"N Ozawa","year":"2021","unstructured":"Ozawa\u00a0N, Yokobori\u00a0T, Osone\u00a0K et al (2021) PD-L1 upregulation is associated with activation of the DNA double-strand break repair pathway in patients with colitic cancer. Sci Rep 11(1):13077. https:\/\/doi.org\/10.1038\/s41598-021-92530-3","journal-title":"Sci Rep"},{"key":"1207_CR21","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3389\/fimmu.2019.00277","volume":"10","author":"D Parada Venegas","year":"2019","unstructured":"Parada Venegas\u00a0D, De la Fuente\u00a0MK, Landskron\u00a0G et al (2019) Short chain fatty acids (SCFas)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases. Front Immunol 10:277","journal-title":"Front Immunol"},{"key":"1207_CR22","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1093\/aje\/kws375","volume":"177","author":"B Pasternak","year":"2013","unstructured":"Pasternak\u00a0B, Svanstrom\u00a0H, Schmiegelow\u00a0K et\u00a0al (2013) Use of azathioprine and the risk of cancer in inflammatory bowel disease. Am J Epidemiol 177:1296\u20131305","journal-title":"Am J Epidemiol"},{"key":"1207_CR23","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1093\/jnci\/91.11.916","volume":"91","author":"JD Potter","year":"1999","unstructured":"Potter\u00a0JD (1999) Colorectal cancer: molecules and populations. J\u00a0Natl Cancer Inst 91:916\u2013932","journal-title":"J Natl Cancer Inst"},{"key":"1207_CR24","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.18632\/oncotarget.13715","volume":"8","author":"X Qiu","year":"2017","unstructured":"Qiu\u00a0X, Ma\u00a0J, Wang\u00a0K et al (2017) Chemopreventive effects of 5\u2011aminosalicylic acid on inflammatory bowel disease-associated colorectal cancer and dysplasia: a\u00a0systematic review with meta-analysis. Oncotarget 8:1031\u20131045","journal-title":"Oncotarget"},{"key":"1207_CR25","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41590-021-00889-2","volume":"22","author":"J Quandt","year":"2021","unstructured":"Quandt\u00a0J, Arnovitz\u00a0S, Haghi\u00a0L et al (2021) Wnt-beta-catenin activation epigenetically reprograms T(reg) cells in inflammatory bowel disease and dysplastic progression. Nat Immunol 22:471\u2013484","journal-title":"Nat Immunol"},{"key":"1207_CR26","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1093\/ecco-jcc\/jjab178","volume":"16","author":"T Raine","year":"2022","unstructured":"Raine\u00a0T, Bonovas\u00a0S, Burisch\u00a0J et\u00a0al (2022) ECCO guidelines on therapeutics in ulcerative colitis: medical treatment. J\u00a0Crohns Colitis 16:2\u201317","journal-title":"J Crohns Colitis"},{"key":"1207_CR27","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1053\/j.gastro.2021.04.042","volume":"161","author":"K Rajamaki","year":"2021","unstructured":"Rajamaki\u00a0K, Taira\u00a0A, Katainen\u00a0R et al (2021) Genetic and epigenetic characteristics of inflammatory bowel disease-associated colorectal cancer. Gastroenterology 161:592\u2013607","journal-title":"Gastroenterology"},{"key":"1207_CR28","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1080\/19490976.2017.1379637","volume":"9","author":"ML Richard","year":"2018","unstructured":"Richard\u00a0ML, Liguori\u00a0G, Lamas\u00a0B et al (2018) Mucosa-associated microbiota dysbiosis in colitis associated cancer. Gut Microbes 9:131\u2013142","journal-title":"Gut Microbes"},{"key":"1207_CR29","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jcmgh.2020.05.012","volume":"11","author":"YH Sheng","year":"2021","unstructured":"Sheng\u00a0YH, Giri\u00a0R, Davies\u00a0J et al (2021) A nucleotide analog prevents colitis-associated cancer via beta-catenin independently of inflammation and autophagy. Cell Mol Gastroenterol Hepatol 11:33\u201353","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"1207_CR30","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1084\/jem.20181639","volume":"216","author":"MT Sorbara","year":"2019","unstructured":"Sorbara\u00a0MT, Dubin\u00a0K, Littmann\u00a0ER et al (2019) Inhibiting antibiotic-resistant enterobacteriaceae by microbiota-mediated intracellular acidification. J\u00a0Exp Med 216:84\u201398","journal-title":"J Exp Med"},{"key":"1207_CR31","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1002\/ibd.20074","volume":"13","author":"JP Terdiman","year":"2007","unstructured":"Terdiman\u00a0JP, Steinbuch\u00a0M, Blumentals\u00a0WA et al (2007) 5\u2011Aminosalicylic acid therapy and the risk of colorectal cancer among patients with inflammatory bowel disease. Inflamm Bowel Dis 13:367\u2013371","journal-title":"Inflamm Bowel Dis"},{"key":"1207_CR32","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.ccell.2015.03.001","volume":"27","author":"SL Topalian","year":"2015","unstructured":"Topalian\u00a0SL, Drake\u00a0CG, Pardoll\u00a0DM (2015) Immune checkpoint blockade: a common denominator approach to cancer therapy. Cancer Cell 27:450\u2013461","journal-title":"Cancer Cell"},{"key":"1207_CR33","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1053\/j.gastro.2020.12.036","volume":"160","author":"AM Wijnands","year":"2021","unstructured":"Wijnands\u00a0AM, de Jong\u00a0ME, Lutgens\u00a0MWMD et al (2021) Prognostic factors for advanced colorectal neoplasia in inflammatory bowel disease: systematic review and meta-analysis. Gastroenterology 160:1584\u20131598","journal-title":"Gastroenterology"},{"key":"1207_CR34","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1016\/S0002-9440(10)65438-7","volume":"154","author":"RF Willenbucher","year":"1999","unstructured":"Willenbucher\u00a0RF, Aust\u00a0DE, Chang\u00a0CG et al (1999) Genomic instability is an early event during the progression pathway of ulcerative-colitis-related neoplasia. Am J Pathol 154:1825\u20131830","journal-title":"Am J Pathol"},{"key":"1207_CR35","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/s43018-020-0078-7","volume":"1","author":"Y Yang","year":"2020","unstructured":"Yang\u00a0Y, Gharaibeh\u00a0RZ, Newsome\u00a0RC et\u00a0al (2020) Amending microbiota by targeting intestinal inflammation with TNF blockade attenuates development of colorectal cancer. Nat Cancer 1:723\u2013734","journal-title":"Nat Cancer"},{"key":"1207_CR36","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.bbrc.2018.10.136","volume":"506","author":"Y Zhang","year":"2018","unstructured":"Zhang\u00a0Y, Weng\u00a0Y, Gan\u00a0H et\u00a0al (2018) Streptococcus gallolyticus conspires myeloid cells to promote tumorigenesis of inflammatory bowel disease. Biochem Biophys Res Commun 506:907\u2013911","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Die Pathologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-023-01207-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00292-023-01207-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-023-01207-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T11:02:54Z","timestamp":1692961374000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00292-023-01207-3"}},"subtitle":["Ein Update","An update"],"short-title":[],"issued":{"date-parts":[[2023,6,13]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["1207"],"URL":"https:\/\/doi.org\/10.1007\/s00292-023-01207-3","relation":{},"ISSN":["2731-7188","2731-7196"],"issn-type":[{"type":"print","value":"2731-7188"},{"type":"electronic","value":"2731-7196"}],"subject":[],"published":{"date-parts":[[2023,6,13]]},"assertion":[{"value":"16 May 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"D.E.\u00a0Aust, G.B.\u00a0Baretton und U.\u00a0Sommer geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}